The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Related News Articles

Headline
A federal grand jury has charged four individuals from a China-based group known as APT40 with targeting computer systems in the United States and abroad…
Headline
The White House yesterday announced an interagency task force and other initiatives to protect U.S. organizations from ransomware attacks. The task force…
Headline
Microsoft has released out-of-band security updates to address a remote code execution vulnerability — known as PrintNightmare (CVE-2021-34527) — in the…
Headline
The FBI and Cybersecurity & Infrastructure Security Agency July 4 released guidance to respond to the recent supply-chain ransomware attack leveraging a…
Headline
The Computer Emergency Response Team Coordination Center (CERT/CC), part of the Software Engineering Institute at Carnegie Mellon University, this week…
Headline
The National Institute of Standards and Technology last week released a definition of critical software, which the Cybersecurity & Infrastructure Security…